ArticlePeerJ2022

Sophocarpine inhibits tumor progression by antagonizing the PI3K/AKT/mTOR signaling pathway in castration-resistant prostate cancer.

Min Weng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.